Company Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally.
The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer.
It also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Covid-19 testing services.
The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests.
It has license agreements with MAYO Foundation for Medical Education and Research, and Johns Hopkins University.
Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.
| Country | United States |
| Founded | 1995 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 6,600 |
| CEO | Kevin T. Conroy |
Contact Details
Address: 5505 Endeavor Lane Madison, Wisconsin 53719 United States | |
| Phone | 608-284-5700 |
| Website | exactsciences.com |
Stock Details
| Ticker Symbol | EXAS |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001124140 |
| CUSIP Number | 30063P105 |
| ISIN Number | US30063P1057 |
| Employer ID | 20-4782291 |
| SIC Code | 8071 |
Key Executives
| Name | Position |
|---|---|
| Kevin T. Conroy | Chairman of The Board and Chief Executive Officer |
| Jeffrey T. Elliott CFA | Executive Vice President and Chief Financial Officer |
| Sarah Condella | Executive Vice President of Human Resources |
| Everett V. Cunningham | Chief Commercial Officer |
| Dr. Jorge A. Garces Ph.D. | Chief Science Officer |
| Nassar Nizami | Chief Information Officer |
| Megan Jones | Associate Manager of Investor Relations |
| Tim Caprez | Chief Compliance Counsel and Vice President |
| James Herriott | Senior Vice President, General Counsel and Secretary |
| Vic Parker | Head of Sales |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 17, 2024 | 8-K | Current Report |
| Apr 15, 2024 | 8-K | Current Report |
| Apr 2, 2024 | 144 | Filing |
| Apr 1, 2024 | 144 | Filing |
| Mar 28, 2024 | 144 | Filing |
| Mar 1, 2024 | 144 | Filing |
| Mar 1, 2024 | 144 | Filing |
| Mar 1, 2024 | 144 | Filing |
| Mar 1, 2024 | 144 | Filing |
| Mar 1, 2024 | 144 | Filing |